Form 4: Cross Country Healthcare CEO John Martins Acquires 25,261 Shares Through Performance Share Settlement

Sentiment:

SEC Form 4 Filing


John Anthony Martins, CEO of Cross Country Healthcare, acquired 25,261 shares of common stock on March 19, 2025, through the settlement of performance shares.

Summary

  • On March 19, 2025, John Anthony Martins, the President and CEO of Cross Country Healthcare, Inc. (CCRN), acquired 25,261 shares of common stock.
  • The acquisition was a result of the settlement of performance shares granted on March 31, 2022, under the company's Omnibus Stock Incentive Plan.
  • These performance shares were settled based on the achievement of pre-defined performance targets and were payable in shares of restricted stock.
  • Following the transaction, Martins directly owns 180,762 shares of Cross Country Healthcare stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The CEO acquiring shares based on performance targets suggests confidence in the company's performance and alignment of interests with shareholders.

Positives

  • The acquisition of shares by the CEO demonstrates confidence in the company's future performance.
  • The performance shares were settled based on the achievement of performance targets, indicating successful execution of company strategy.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's acquisition of shares through a pre-existing compensation plan.

Stakeholder Impact

  • The acquisition of shares by the CEO could positively influence shareholder sentiment.

Key Dates

DateDescription
03/31/2022Date of grant for the performance shares under the Issuer's Omnibus Stock Incentive Plan.
03/19/2025Date of transaction: John A. Martins acquired 25,261 shares of common stock.
03/21/2025Date of signature for the Form 4 filing.

Keywords

Cross Country Healthcare, John Anthony Martins, CCRN, Form 4, Performance Shares, Stock Acquisition, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.